Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
Podcast: Migraine and the gender pain gap
Migraine is sometimes misunderstood as a ‘women’s disorder’, which presents barriers to diagnosis, treatment and research investment.
One credential, many paths
Becoming credentialed opens up a world of possibilities, with fulfilling opportunities that make use of pharmacists' clinical skills.
Pharmacists recognised for excellence
The PSA recognised outstanding pharmacists at its 2024 South Australia and Northern Territory Excellence Awards in Adelaide over the weekend.
How pharmacy fared in this year’s Budget
The new federal government last night delivered its 2022–23 ‘bread and butter’ Budget amid a growing cost-of-living crisis.
Top five pharmacy Budget asks
The PSA has provided a blueprint to help Federal Treasurer Jim Chalmers improve primary care and enhance medicine safety for all Australians.
Role of pharmacists recognised around the world
Pharmacists across Australia and the globe came together on 25 September to celebrate the 10th annual World Pharmacists Day.
With the theme of ‘safe and...
